146 results on '"Jagsi, Reshma"'
Search Results
2. Gender differences in endowed chairs in Departments of Psychiatry and Behavioral Sciences from the top-10 NIH-funded medical schools in the US
- Author
-
Roubinov, Danielle, Gold, Jessica A., Jia, Lena S., Griffith, Kent A., Dahiya, Priya, Jagsi, Reshma, and Mangurian, Christina
- Published
- 2022
- Full Text
- View/download PDF
3. The Effect of Wire Versus Magnetic Seed Localization on Lumpectomy Cavity Size.
- Author
-
Dykstra, Michael, Thompson, Jessica, Aldous, Jessica, Jiang, Shannon, Hughes, Tasha, Hayman, James, Dragovic, Aleksandar, Shah, Jennifer, Chang, Alfred, Speers, Corey, Sabel, Michael, Dossett, Lesly, Schipper, Matthew, and Jagsi, Reshma
- Abstract
Our purpose was to assess whether an association exists between surgical localization technique and lumpectomy cavity size on radiation therapy planning computed tomography (CT) scan. A single-institution retrospective review was conducted of women undergoing breast conserving surgery with wire or magnetic seed guided lumpectomy followed by adjuvant radiation therapy from 2018 to 2021. Patients of a surgeon only performing 1 localization technique or undergoing bracketed localization were excluded. The primary outcome was lumpectomy cavity size on simulation CT. Confounding due to imbalance in patient and tumor factors was addressed with overlap weights derived from a propensity score analysis and used in a weighted multivariable analysis. Secondary outcomes included positive margins, total pathologic volume, boost delivery, and boost modality. Of 617 women who received lumpectomy during the study period, 387 were included in final analysis. Tumors of patients undergoing seed localization were more likely unifocal, assessable by ultrasound, and smaller. Seed use rates ranged from 27.7% to 70.7% per surgeon. There was no difference in positive margins (6.4 vs 5.4%, P =.79) or second surgeries (9.4 vs 8.1%, P =.79) between groups. Close margin rates were similar for ductal carcinoma in situ (P =.35) and invasive carcinoma (P =.97). In unadjusted bivariable analyses, wire localization was associated with larger total pathology volume (P =.004), but localization technique showed no association with CT cavity volume (P =.15). After adjusting for potentially confounding variables, multivariable analysis failed to show an association between localization technique and either CT cavity (P =.35) or total path volume (P =.08). There was no difference in indicated-boost delivery (P =.15) or electron boost (P =.14) by localization technique. There was no significant difference in CT cavity size by localization technique, suggesting choice between surgical techniques does not impede radiation therapy boost delivery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review
- Author
-
Dahn, Hannah M., Boersma, Liesbeth J., de Ruysscher, Dirk, Meattini, Icro, Offersen, Birgitte V., Pignol, Jean-Philippe, Aristei, Cynthia, Belkacemi, Yazid, Benjamin, Dori, Bese, Nuran, Coles, Charlotte E., Franco, Pierfrancesco, Ho, Alice, Hol, Sandra, Jagsi, Reshma, Kirby, Anna M., Marrazzo, Livia, Marta, Gustavo N., Moran, Meena S., Nichol, Alan M., Nissen, Henrik D., Strnad, Vratislav, Zissiadis, Yvonne E., Poortmans, Philip, and Kaidar-Person, Orit
- Published
- 2021
- Full Text
- View/download PDF
5. ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer
- Author
-
Kaidar-Person, Orit, Vrou Offersen, Birgitte, Hol, Sandra, Arenas, Meritxell, Aristei, Cynthia, Bourgier, Celine, Cardoso, Maria Joao, Chua, Boon, Coles, Charlotte E., Engberg Damsgaard, Tine, Gabrys, Dorota, Jagsi, Reshma, Jimenez, Rachel, Kirby, Anna M., Kirkove, Carine, Kirova, Youlia, Kouloulias, Vassilis, Marinko, Tanja, Meattini, Icro, Mjaaland, Ingvil, Nader Marta, Gustavo, Witt Nystrom, Petra, Senkus, Elzbieta, Skyttä, Tanja, Tvedskov, Tove F., Verhoeven, Karolien, and Poortmans, Philip
- Published
- 2019
- Full Text
- View/download PDF
6. Out-of-Pocket Cost Modeling of Adjuvant Radiation Therapy Duration in Standard-of-Care Early Stage Breast Cancer Treatment Across Medicaid and Medicare Plans.
- Author
-
Wu, Victoria S., Khlopin, Martha, Jagsi, Reshma, and McClelland III, Shearwood
- Abstract
For early stage breast cancer (BC), the choice of radiation therapy duration (1 vs 3 weeks) is highly debated. Cost and financial toxicity are major concerns that patients with BC face. Nonetheless, there remain limited discussions providing granular details of the role of insurance in the aggregate cost of 1 week versus 3 weeks of radiation therapy for patients. This project aims to disaggregate costs by plan to increase transparency of out-of-pocket (OOP) cost estimates in radiation therapy. Treatment procedures were determined through the National Comprehensive Cancer Network guidelines. OOP treatment costs, deductibles, and copays/coinsurance were calculated by using Medicaid, Original Medicare, Medigap Plan G, and Medicare Part D prescription plans. The medicare.gov, medicaid.oh.gov, aarpmedicareplans.com, and the physician fee schedule from cms.gov were used to determine costs by treatment. Price estimates reflect actual costs per insurance plan rather than costs estimated from claims data. All procedures were considered to be performed in an Ohio hospital setting. One-week radiation therapy was defined as 5 fractions without boost, and 3-week radiation therapy was defined as 15 fractions without boost. Medicare beneficiaries with Original Medicare coverage face an OOP treatment charge of $649.24 for 1 week of radiation therapy and $1006.20 for 3 weeks of radiation therapy. Assuming the deductible is met postlumpectomy, Medigap Plan G beneficiaries are faced with no additional charges for both lengths of radiation therapy. Similarly for Medicaid beneficiaries (assuming treatment is approved by Medicaid), all expenses are covered without limit, resulting in no OOP expense. Considerations of 1 and 3 weeks of radiation therapy for postlumpectomy early-stage BC are often dependent on cancer characteristics and patient preferences. This model (based on actual cost estimates per insurance plan rather than claims data) compares OOP costs across Medicaid and Medicare plans, which more holistically informs providers and patients in radiation therapy duration decision making. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Pectoralis Muscle Dosimetry and Posttreatment Rehabilitation Utilization for Patients With Early-Stage Breast Cancer.
- Author
-
Takayesu, Jamie S.K., Jiang, Shannon J., Marsh, Robin, Moncion, Alexander, Smith, Sean R., Pierce, Lori J., Jagsi, Reshma, and Lipps, David B.
- Abstract
Up to 50% of women treated for localized breast cancer will experience some degree of arm or shoulder morbidity. Although radiation is thought to contribute to this morbidity, the mechanism remains unclear. Prior studies have shown biologic and radiographic changes in the pectoralis muscles after radiation. This study thus aimed to investigate the relationship between radiation to the pectoralis muscles and referrals for rehabilitation services posttreatment for arm and shoulder morbidity. A retrospective 1:1 matched case-control study was conducted for patients with breast cancer who were and were not referred for breast or shoulder rehabilitation services between 2014 and 2019 at a single academic institution. Patients were included if they had a lumpectomy and adjuvant radiation. Patients who underwent an axillary lymph node dissection were excluded. Cohorts were matched based on age, axillary surgery, and use of radiation boost. Muscle doses were converted to equivalent dose in 2 Gy fractions assuming an α:β ratio of 2.5 and were compared between the 2 groups. In our cohort of 50 patients of a median age 60 years (interquartile range, 53-68 years), 36 patients (72%) underwent a sentinel lymph node biopsy in addition to a lumpectomy. Although pectoralis muscle doses were generally higher in those receiving rehabilitation services, this was not statistically significant. Pectoralis major V20-40 Gy reached borderline significance, as did pectoralis major mean dose (17.69 vs 20.89 Gy; P =.06). In this limited cohort of patients, we could not definitively conclude a relationship between pectoralis muscle doses and use of rehabilitation services. Given the borderline significant findings, this should be further investigated in a larger cohort. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. A cardiac contouring atlas for radiotherapy
- Author
-
Duane, Frances, Aznar, Marianne C., Bartlett, Freddie, Cutter, David J., Darby, Sarah C., Jagsi, Reshma, Lorenzen, Ebbe L., McArdle, Orla, McGale, Paul, Myerson, Saul, Rahimi, Kazem, Vivekanandan, Sindu, Warren, Samantha, and Taylor, Carolyn W.
- Published
- 2017
- Full Text
- View/download PDF
9. Optimizing Informed Consent in Cancer Clinical Trials.
- Author
-
Perni, Subha, Jimenez, Rachel, and Jagsi, Reshma
- Abstract
The concept of informed consent has evolved considerably over the course of the 20th century, leading to its establishment as a foundational ethical principle for the conduct of biomedical research in the United States. Even though it is now a highly regulated part of cancer research, the process of obtaining informed consent is often impeded by systemic, clinician, and patient factors that require both small- and large-scale intervention. New challenges and considerations continue to emerge due to innovations in clinical trial design, increases in utilization of genomic sequencing, and advances in genomic editing and artificial intelligence. We present a review of the history, policy, pragmatic challenges, and evolving role of the central ethical tenet of informed consent in clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Changes in pectoralis major stiffness and thickness following radiotherapy for breast cancer: A 12-month follow-up case series
- Author
-
Wolfram, Susann, Takayesu, Jamie Seul Ki, Pierce, Lori Jo, Jagsi, Reshma, and Lipps, David Benjamin
- Published
- 2023
- Full Text
- View/download PDF
11. Tailoring the Omission of Radiotherapy for Early-Stage Breast Cancer Based on Tumor Biology.
- Author
-
Allen, Steven G., Speers, Corey, and Jagsi, Reshma
- Abstract
Advances in our understanding of tumor biology now permit greater personalization of radiotherapy for early-stage breast cancer. De-escalation of radiotherapy is an important opportunity that exists due to improvements in breast imaging, surgery, pathology, and systemic therapy. These modern tools, in addition to molecular subtype and prediction assays, have allowed us to select certain patients with breast cancer based on favorable biology who are at sufficiently low-risk of local recurrence that they may reasonably consider the omission of radiotherapy to reduce toxicity and burden. For decades, clinical trials have been conducted to try to identify the population of patients in whom the risk of recurrence in the absence of radiotherapy is sufficiently small that omission of adjuvant radiotherapy might acceptably be considered after breast conserving surgery. Trials to date have largely included patients with estrogen receptor-positive breast cancer selected based upon clinicopathologic characteristics alone and have yet to identify a patient population for whom radiotherapy is not effective. They have, however, identified women with lower absolute risks of locoregional recurrence with radiotherapy omission, and current guidelines do recognize this patient population as candidates for radiotherapy omission after breast conserving surgery. Studies that assess not just clinicopathologic features but predictive molecular biomarkers of the underlying biology are currently ongoing. This manuscript will briefly review historical trials evaluating the role of radiotherapy after breast conserving surgery as well as discuss the exciting ongoing trials in hormone receptor-positive disease leveraging our growing appreciation of tumor biology and molecular prediction to identify a population of patients who may reasonably consider omitting radiotherapy after breast conserving surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Evaluation of Dose Accuracy in the Near-Surface Region for Whole Breast Irradiation Techniques in a Multi-institutional Consortium.
- Author
-
Moncion, Alexander, Wilson, Melissa, Ma, Ruimei, Marsh, Robin, Burmeister, Jay, Dryden, Daniel, Lack, Danielle, Grubb, Margaret, Mayville, Alan, Jursinic, Paul, Dess, Kathryn, Kamp, Justin, Young, Kellen, Dilworth, Joshua T., Kestin, Larry, Jagsi, Reshma, Mietzel, Melissa, Vicini, Frank, Pierce, Lori J., and Moran, Jean M.
- Abstract
To assess the accuracy of dose calculations in the near-surface region for different treatment planning systems (TPSs), treatment techniques, and energies to improve clinical decisions for patients receiving whole breast irradiation (WBI). A portable custom breast phantom was designed for dose measurements in the near-surface regions. Treatment plans of varying complexities were created at 8 institutions using 4 different TPSs on an anonymized patient data set (50 Gy in 25 fractions) and peer reviewed by participants. The plans were recalculated on the phantom data set. The phantom was aligned with predetermined shifts and laser marks or cone beam computed tomography, and the irradiation was performed using a variety of linear accelerators at the participating institutions. Dose was measured with radiochromic film placed at 0.5 and 1.0 cm depth and 3 locations per depth within the phantom. The film was scanned and analyzed >24 hours postirradiation. The percentage difference between the mean of the measured and calculated dose across the participating centers was -0.2 % ± 2.9%, with 95% of measurements within 6% agreement. No significant differences were found between the mean of the calculated and measured dose for all TPSs, treatment techniques, and energies at all depths and laterality investigated. Furthermore, no significant differences were observed between the mean of measured dose and the prescription dose of 2 Gy per fraction. These results demonstrate that dose calculations for clinically relevant WBI plans are accurate to within 6% of measurements in the near-surface region for various complexities, TPSs, linear accelerators, and beam energies. This work lays the necessary foundation for future studies investigating the correlation between near-surface dose and acute skin toxicities. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. The Michigan Radiation Oncology Quality Consortium: A Novel Initiative to Improve the Quality of Radiation Oncology Care.
- Author
-
Jagsi, Reshma, Schipper, Matthew, Mietzel, Melissa, Pandya, Raveena, Moran, Jean M., Matuszak, Martha, Vicini, Frank, Jolly, Shruti, Paximadis, Peter, Mancini, Brandon, Griffith, Kent, Hayman, James, and Pierce, Lori
- Subjects
- *
CANCER treatment , *RANDOM effects model , *ONCOLOGY , *ONCOLOGY nursing , *ONCOLOGISTS , *RADIATION - Abstract
Purpose: Numerous quality measures have been proposed in radiation oncology, and initiatives to improve access to high-complexity care, quality, and equity are needed. We describe the design and evaluate effect of a voluntary statewide collaboration for quality improvement in radiation oncology initiated a decade ago.Methods and Materials: We evaluate compliance before and since implementation of annual metrics for quality improvement, using an observational data set with information from more than 20,000 patients treated in the 28 participating radiation oncology practices. At thrice-yearly meetings, experts have spoken regarding trends within the field and inspired discussions regarding potential targets for quality improvement. Blinded data on practices at various sites have been provided. Following Standards for Quality Improvement Reporting Excellence guidelines, we describe the approach and measures the program has implemented. To evaluate effect, we compare compliance at baseline and now with active measures using mixed effects regression models with site-level random effects.Results: Compliance has increased, including use of guideline-concordant hypofractionated radiation therapy, doses to targets or normal tissues, motion management, and consistency in delineating and naming contoured structures (a precondition for quality evaluation). For example, use of guideline-concordant hypofractionation for breast cancer increased from 47% to 97%, adherence to target coverage goals and heart dose limits for dose increased from 46% to 86%, motion assessment in patients with lung cancer increased from 52% to 94%, and use of standard nomenclature increased from 53% to 82% for lung patients and from 80% to 94% for breast patients (all P < .001).Conclusions: Although observational analysis cannot fully exclude secular trends, contextual data revealing slow uptake of best practices elsewhere in the United States and qualitative feedback from participants suggests that this initiative has improved the consistency, efficiency, and quality of radiation oncology care in its member practices and may be a model for oncology quality improvement more generally. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
14. The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials.
- Author
-
VanderWalde, Noam, Moughan, Jennifer, Lichtman, Stuart M., Jagsi, Reshma, Ballo, Matthew, VanderWalde, Ari, Mohiuddin, Mohammed, Meropol, Neal J., Kachnic, Lisa, Berger, Adam, Ajani, Jaffer, Anne, Rani, Hopkins, Judith L., Arora, Amit, Meyer, Joshua, Ellsworth, Susannah G., Lee, R. Jeffrey, Green, Nathan, and Crane, Christopher H.
- Abstract
Expected toxicity from chemoradiation (CRT) is an important factor in treatment decisions but is poorly understood in older adults with lower gastrointestinal (GI) malignancies. Our objective was to compare acute adverse events (AAEs) of older and younger adults with lower GI malignancies treated on NRG studies. Data from 6 NRG trials, testing combined modality therapy in patients with anal or rectal cancer, were used to test the hypothesis that older age was associated with increased AAEs. AAEs and compliance with protocol-directed therapy were compared between patients aged ≥70 and < 70. Categorical variables were compared across age groups using the chi-square test. The association of age on AAEs was evaluated using a covariate-adjusted logistic regression model, with odds ratio (OR) reported. To adjust for multiple comparisons, a p -value <0.01 was considered statistically significant. There were 2525 patients, including 380 patients ≥70 years old (15%) evaluable. Older patients were more likely to have worse baseline performance status (PS 1 or 2) (23% vs. 16%, p = 0.001), but otherwise baseline characteristics were similar. Older patients were less likely to complete their chemotherapy (78% vs. 87%, p < 0.001), but had similar RT duration. On univariate analysis, older patients were more likely to experience grade ≥ 3 GI AAEs (36% vs. 23%, p < 0.001), and less likely to experience grade ≥ 3 skin AAEs (8% vs. 14%, p = 0.002). On multivariable analysis, older age was associated with grade ≥ 3 GI AAE (OR 1.93, 95% CI: 1.52, 2.47, p < 0.001) after adjusting for sex, race, PS, and disease site. Older patients with lower GI cancers who underwent CRT were less likely to complete chemotherapy and had higher rates of grade 3+ GI AAEs. These results can be used to counsel older adults prior to treatment and manage expected toxicities throughout pelvic CRT. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.
- Author
-
Jagsi, Reshma, Griffith, Kent A., Vicini, Frank A., Abu-Isa, Eyad, Bergsma, Derek, Bhatt, Amit, Dilworth, Joshua T., Dominello, Michael, Franklin, Stephen, Heimburger, David K., Kaufman, Isaac, Kocheril, Paul G., Kretzler, Annette E., Paximadis, Peter, Radawski, Jeffrey D., Walker, Eleanor M., and Pierce, Lori
- Subjects
- *
TRIPLE-negative breast cancer , *DOSE fractionation , *PREVENTIVE medicine - Abstract
Purpose: Questions remain about whether moderately hypofractionated whole-breast irradiation is appropriate for patients with triple-negative breast cancer.Methods and Materials: Using the prospective database of a multicenter, collaborative quality improvement consortium, we identified patients with node-negative, triple-negative breast cancer who received whole-breast irradiation with either moderate hypofractionation or conventional fractionation. Using inverse probability of treatment weighting (IPTW), we compared outcomes using the Kaplan-Meier product-limit estimation method with Cox regression models estimating the hazard ratio for time-to-event endpoints between groups.Results: The sample included 538 patients treated at 18 centers in 1 state in the United States, of whom 307 received conventionally fractionated whole-breast irradiation and 231 received moderately hypofractionated whole-breast irradiation. The median follow-up time was 5.0 years (95% confidence interval [CI], 4.77-5.15 years). The 5-year IPTW estimates for freedom from local recurrence were 93.6% (95% CI, 87.8%-96.7%) in the moderate hypofractionation group and 94.4% (95% CI, 90.3%-96.8%) in the conventional fractionation group. The hazard ratio was 1.05 (95% CI, 0.51-2.17; P = .89). The 5-year IPTW estimates for recurrence-free survival were 87.8% (95% CI, 81.0%-92.4%) in the moderate hypofractionation group and 88.4% (95% CI 83.2%-92.1%) in the conventional fractionation group. The hazard ratio was 1.02 (95% CI, 0.62-1.67; P = .95). The 5-year IPTW estimates for overall survival were 96.6% (95% CI, 92.0%-98.5%) in the moderate hypofractionation group and 93.4% (95% CI, 88.7%-96.1%) in the conventional fractionation group. The hazard ratio was 0.65 (95% CI, 0.30-1.42; P = .28).Conclusions: Analysis of outcomes in this large observational cohort of patients with triple-negative, node-negative breast cancer treated with whole-breast irradiation revealed no differences by dose fractionation. This adds evidence to support the use of moderate hypofractionation in patients with triple-negative disease. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
16. Comparative Effectiveness Analysis of 3D-Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy (IMRT) in a Prospective Multicenter Cohort of Patients With Breast Cancer.
- Author
-
Jagsi, Reshma, Griffith, Kent A., Moran, Jean M., Matuszak, Martha M., Marsh, Robin, Grubb, Margaret, Abu-Isa, Eyad, Dilworth, Joshua T., Dominello, Michael M., Heimburger, David, Lack, Danielle, Walker, Eleanor M., Hayman, James A., Vicini, Frank, Pierce, Lori J., and Michigan Radiation Oncology Quality Consortium
- Subjects
- *
RADIOTHERAPY , *INTENSITY modulated radiotherapy , *BREAST cancer , *ADJUVANT treatment of cancer , *CANCER patients , *COMPUTERS in medicine , *RESEARCH , *RESEARCH methodology , *EVALUATION research , *COMPARATIVE studies , *BREAST tumors , *LONGITUDINAL method - Abstract
Purpose: Simple intensity modulation of radiation therapy reduces acute toxicity compared with 2-dimensional techniques in adjuvant breast cancer treatment, but it remains unknown whether more complex or inverse-planned intensity modulated radiation therapy (IMRT) offers an advantage over forward-planned, 3-dimensional conformal radiation therapy (3DCRT).Methods and Materials: Using prospective data regarding patients receiving adjuvant whole breast radiation therapy without nodal irradiation at 23 institutions from 2011 to 2018, we compared the incidence of acute toxicity (moderate-severe pain or moist desquamation) in patients receiving 3DCRT versus IMRT (either inverse planned or, if forward-planned, using ≥5 segments per gantry angle). We evaluated associations between technique and toxicity using multivariable models with inverse-probability-of-treatment weighting, adjusting for treatment facility as a random effect.Results: Of 1185 patients treated with 3DCRT and conventional fractionation, 650 (54.9%) experienced acute toxicity; of 774 treated with highly segmented forward-planned IMRT, 458 (59.2%) did; and of 580 treated with inverse-planned IMRT, 245 (42.2%) did. Of 1296 patients treated with hypofractionation and 3DCRT, 432 (33.3%) experienced acute toxicity; of 709 treated with highly segmented forward-planned IMRT, 227 (32.0%) did; and of 623 treated with inverse-planned IMRT, 164 (26.3%) did. On multivariable analysis with inverse-probability-of-treatment weighting, the odds ratio for acute toxicity after inverse-planned IMRT versus 3DCRT was 0.64 (95% confidence interval, 0.45-0.91) with conventional fractionation and 0.41 (95% confidence interval, 0.26-0.65) with hypofractionation.Conclusions: This large, prospective, multicenter comparative effectiveness study found a significant benefit from inverse-planned IMRT compared with 3DCRT in reducing acute toxicity of breast radiation therapy. Future research should identify the dosimetric differences that mediate this association and evaluate cost-effectiveness. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
17. Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736).
- Author
-
VanderWalde, Noam A., Dockter, Travis, Wakefield, Daniel V., Satele, Daniel, Sloan, Jeff, Jagsi, Reshma, Lichtman, Stuart M., Freedman, Rachel A., Lafky, Jacqueline M., Muss, Hyman, Cohen, Harvey Jay, Le-Rademacher, Jennifer, and Jatoi, Aminah
- Abstract
Background : Older adults are under-represented in cancer clinical trials. However, it remains unclear which types of trials under-enroll aging patients. We aimed to identify associations between trial characteristics and disparate enrollment of older adults onto trials sponsored by the Alliance for Clinical Trials in Oncology (Alliance). Methods : Actual age ≥ 65 percentage and trial data were extracted from the Alliance closed study list. Each trial, based on its cancer type and years of enrollment, was assigned an expected age ≥ 65 percentage extracted from the Surveillance, Epidemiology, and End Results (SEER) US population-based database. Enrollment disparity difference (EDD), the difference between the expected age ≥ 65 percentage and the actual age ≥ 65 percentage, was calculated for each trial. Linear regression determined trial variables associated with larger EDDs and variables with an overall association p -value <0.20 were included in a multivariable fixed-effects linear model. Results : The median age of 66,708 patients across 237 trials was 60 years (range 18–102). The average actual age ≥ 65 percentage enrolled per trial was lower than each trial's expected age ≥ 65 percentage average (39% vs. 58%; EDD 19, 95% CI 17.1–21.3%, p < 0.0001). In multivariable analyses, non-genitourinary (GU) cancer types (p < 0.001), trimodality+ trials (estimate 8.78, 95%CI 2.21–15.34, p = 0.009), and phase 2 trials (estimate 4.43 95% CI -0.06-8.91; p = 0.05) were all associated with larger EDDs. Conclusions : Disparate enrollment of older adults is not equal across cancer trials. Future strategies to improve older adult inclusion should focus on trial types associated with the highest disparate enrollment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Outcomes of a pilot faculty mentoring program
- Author
-
Tracy, Erin E., Jagsi, Reshma, Starr, Rebecca, and Tarbell, Nancy J.
- Subjects
Medical students -- Vocational guidance ,Mentors -- Methods ,Health - Abstract
A study is conducted to determine whether a junior faculty mentoring program is beneficial to participants and to identify particular positive and negative aspects of such a program to enable others to institute similar programs. The results indicated that the faculty mentoring program had significant benefits for everyone who participated.
- Published
- 2004
19. Are We Missing Acute Toxicities Associated With Hypofractionated Breast Irradiation? A Report From a Large Multicenter Cohort Study.
- Author
-
Beydoun, Hassan, Griffith, Kent A., Jagsi, Reshma, Burmeister, Jacob W., Moran, Jean M., Vicini, Frank A., Hayman, James A., Paximadis, Peter, Boike, Thomas P., Walker, Eleanor M., Pierce, Lori J., and Dominello, Michael M.
- Subjects
- *
DOSE fractionation , *BODY mass index , *COHORT analysis , *IRRADIATION - Abstract
The efficacy and long-term safety of hypofractionated whole breast irradiation (HF-WBI) have been established through multiple randomized trials, yet data about acute toxicities remain more limited. Since 2013, our group has prospectively collected acute toxicity data from weekly treatment evaluations and additional assessment after completion. In 2016, we intentionally shifted the posttreatment assessment follow-up visit from 1 month to 2 weeks to evaluate for missed acute toxicity occurring in that immediate posttreatment window. Here, we report whether 2-week follow-up has resulted in increased detection of acute toxicities compared with 4-week follow-up. We prospectively compared acute toxicity for patients treated with HF-WBI between January 1, 2013, and August 31, 2015 (4 week follow-up cohort) to patients treated between January 1, 2016, and August 31, 2018 (2 week follow-up cohort). Analyses included a multivariable model that adjusted for other factors known to correlate with toxicity. We prospectively defined acute toxicity as maximum breast pain (moderate or severe rating) and/or occurrence of moist desquamation reported 7 days before the completion of radiation therapy (RT) until 42 days after completion. A total of 2689 patients who received postlumpectomy radiation and boost were analyzed; 1862 patients in the 2-week follow-up cohort and 827 in the 4-week follow-up cohort. All acute toxicity measures assessed were statistically similar between follow-up cohorts when compared in an unadjusted fashion. Overall acute composite toxicity was 26.4% and 27.7% for patients in the 4-week follow-up and 2-week follow-up cohorts, respectively. Overall acute composite toxicity remained similar between follow-up cohorts in a multivariable, adjusted model and was significantly related to patient's age, body mass index, smoking status, and treatment technique (intensity-modulated RT vs 3-dimensional conformal radiation therapy) but not follow-up cohort. An earlier posttreatment follow-up for HF-WBI patients did not reveal a significant increased incidence of acute toxicities at 2 weeks compared with 4 weeks. This study provides physicians and patients with additional data on the safety and tolerability of HF-WBI for early stage breast cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Development of an Illustrated Scale for Acute Radiation Dermatitis in Breast Cancer Patients.
- Author
-
Shumway, Dean A., Kapadia, Nirav, Walker, Eleanor M., Griffith, Kent A., Do, Thy Thy, Feng, Mary, Boike, Thomas, Helfrich, Yolanda, DePalma, Bonnie, Gillespie, Erin F., Miller, Alexandria, Hayman, James, Jagsi, Reshma, and Pierce, Lori J.
- Abstract
Scales for rating acute radiation dermatitis (ARD) have not been validated despite decades of clinical use, and little is known regarding the relationship between toxicity scores and patient-reported symptoms. Skin tone also complicates assessment of ARD, and as such we sought to design an illustrated scale to consistently describe ARD across several skin tone types in breast cancer patients undergoing radiation (RT). Patients undergoing RT for breast cancer were enrolled on a prospective study with photographs obtained at 2-week intervals. Photographs were clustered according to the apparent severity of acute radiation dermatitis and a descriptive photonumeric scale was developed. Four clinically experienced raters used both the illustrated photonumeric scale and the Common Terminology Criteria for Adverse Events to independently score the collection of photographs in 2 independent sessions. Among 80 unique patients with 192 photographs, 47 patients (59%) completed questionnaires about their symptoms during RT. Physicians completed toxicity forms at the point-of-care for 52 patients (65%). Photonumeric ratings compared against patient reports of dry and moist desquamation demonstrated high specificity (95% and 93%, respectively) and negative predictive value (84% and 92%), indicating correct identification of patients who did not report dry or moist desquamation. The sensitivity and positive predictive value for separate measures of dry and moist desquamation were considerably lower. A combined measure of any desquamation (dry or moist) portrayed higher diagnostic accuracy, resulting in 72% sensitivity, 93% specificity, 75% positive predictive value, and 92% negative predictive value. Photonumeric ratings of dry or moist desquamation were significantly associated with patient reports of itching, burning or stinging, hurting, and swelling. The Michigan scale for acute radiation dermatitis is a simple grading rubric that is distinguished by characterization of its intra- and interrater reliability and diagnostic accuracy, correlation with patient-reported symptoms of bother and pain, and applicability across the spectrum of skin pigmentation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Hospital Visitation Policies During the SARS-CoV-2 Pandemic.
- Author
-
Weiner, Hillary S., Firn, Janice I., Hogikyan, Norman D., Jagsi, Reshma, Laventhal, Naomi, Marks, Adam, Smith, Lauren, Spector-Bagdady, Kayte, Vercler, Christian J., and Shuman, Andrew G.
- Abstract
A significant change for patients and families during SARs-CoV-2 has been the restriction of visitors for hospitalized patients. We analyzed SARs-CoV-2 hospital visitation policies and found widespread variation in both development and content. This variation has the potential to engender inequity in access. We propose guidance for hospital visitation policies for this pandemic to protect, respect, and support patients, visitors, clinicians, and communities. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiation Therapy.
- Author
-
Laucis, Anna M., Jagsi, Reshma, Griffith, Kent A., Dominello, Michael M., Walker, Eleanor M., Abu-Isa, Eyad I., Dilworth, Joshua T., Vicini, Frank, Kocheril, Paul G., Browne, Cynthia H., Mietzel, Melissa A., Moran, Jean M., Hayman, James A., Pierce, Lori J., and Michigan Radiation Oncology Quality Consortium
- Subjects
- *
RADIOTHERAPY , *ACCELERATED partial breast irradiation , *BREAST , *LUMPECTOMY , *BODY mass index , *CAUCASIAN race , *RADIATION therapy equipment , *POPULATION , *RESEARCH , *RESEARCH methodology , *EVALUATION research , *MEDICAL cooperation , *COMPARATIVE studies , *BREAST tumors - Abstract
Purpose: Hypofractionated radiation therapy is a less burdensome and less costly approach that is efficacious for most patients with early-stage breast cancer. Concerns about racial disparities in adoption of medical advances motivate investigation of the use of hypofractionated radiation in diverse populations. The goal of our study was to determine whether hypofractionated whole breast radiation therapy after breast-conserving surgery was being similarly used across racial groups in the state of Michigan.Methods and Materials: A prospectively collected statewide quality consortium database from 25 institutions was queried for patients with breast cancer who completed hypofractionated (HF) or conventionally fractionated whole breast radiation therapy from January 2012 to December 2018. We used patient-level multivariable modeling to evaluate associations between HF use and race, controlling for patient and facility factors, and multilevel modeling to account for patient clustering within facilities.Results: Of 9634 patients analyzed, 81% self-reported race as white, 17% as black, and 2% as Asian, similar to statewide and national distributions. In addition, 31.7% of whites were treated at teaching centers compared with 66.7% of blacks and 64.8% of Asians. In 2018, HF was used in 72.7% of whites versus 56.7% of blacks and 67.6% of Asians (P = .0411). On patient-level multivariable analysis, black and Asian races were significantly associated with a lower likelihood of HF receipt (P < .001), despite accounting for treatment year, age, laterality, body mass index, breast volume, comorbidities, stage, triple-negative status, intensity modulated radiation therapy use, teaching center treatment, and 2011 American Society for Radiation Oncology Hypofractionation Guideline eligibility. On multilevel analysis, race was no longer significantly associated with HF receipt.Conclusions: We observed that black and Asian patients receive hypofractionated whole breast radiation therapy less often than whites, despite more frequent treatment at teaching centers. Multilevel modeling eliminated this disparity, suggesting that differences in facility-specific HF use appear to have contributed. Further inquiry is needed to determine whether reduction of facility-level variation may reduce disparities in accessing HF treatment. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
23. Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials.
- Author
-
Ludmir, Ethan B., Subbiah, Ishwaria M., Mainwaring, Walker, Miller, Austin B., Lin, Timothy A., Jethanandani, Amit, Espinoza, Andres F., Mandel, Jacob J., Fang, Penny, Smith, Benjamin D., Smith, Grace L., Pinnix, Chelsea C., Sedrak, Mina S., Kimmick, Gretchen G., Stinchcombe, Thomas E., Jagsi, Reshma, Thomas, Charles R., Fuller, C. David, and VanderWalde, Noam A.
- Abstract
Age disparities among cancer clinical trial participants are pervasive and worsening over time. Identification of factors associated with age disparities is critical to improve enrollment of older patients on trials. The incidence and impact of trial eligibility criteria that exclude patients on the basis of age remains opaque. ClinicalTrials.gov was queried for completed oncologic randomized controlled trials (RCTs). Phase 3 RCTs assessing a therapeutic intervention among adult cancer patients were included. Trial eligibility criteria were assessed using the ClinicalTrials.gov website as well as trial publications and protocol documentation. Seven hundred and forty-two trials met inclusion criteria, with a total combined enrollment of 449,720 patients. Upper age restriction enrollment criteria were identified for 10.1% of RCTs; the median age cutoff for restricted trials was 72 years (interquartile range 70–80 years). Linear regression modeling revealed decreasing incidence of age restriction criteria over time, at a rate of −1.1% annually (p =.03); trials initiating enrollment in 2002–2005, for example, had a 16.1% rate of age-restrictive eligibility criteria, compared with 7.6% for trials initiating enrollment in 2010–2014. Use of eligibility criteria that explicitly exclude patients on the basis of age appears to be decreasing with time. Future efforts should aim to better characterize the relationship between eligibility criteria (such as those that exclude patients on the basis of specific organ function) and their association with age disparities among enrolled patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
24. Sexual Harassment in Radiology: Prevalence and Opportunities for Improvement.
- Author
-
Perumalswami, Chithra R. and Jagsi, Reshma
- Abstract
Radiologists have a key role in the delivery of modern medicine and interface with almost every medical subspecialty within health care systems. Radiology requires collaborative team science and continued communication across providers. Essential to these ends is an inclusive and respectful environment. Therefore, sexual harassment cannot be tolerated. This perspective provides an overview of the existing literature on sexual harassment in medicine and sexual harassment in radiology and suggestions for creating change within the field of radiology to address sexual harassment. This article also discusses specific ways that radiologists can be engaged as bystanders who intervene effectively to stop or mitigate problematic situations as they occur. Although individual changes in behavior can be impactful, ultimately, wholesale cultural transformation is key to preventing sexual harassment. Leaders in radiology, like leaders everywhere, must make clear that harassing behaviors will not be tolerated and that those who have committed harassment will be held accountable. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
25. Recommendations for Single-Fraction Radiation Therapy and Stereotactic Body Radiation Therapy in Palliative Treatment of Bone Metastases: A Statewide Practice Patterns Survey.
- Author
-
Gharzai, Laila A., Beeler, Whitney H., Hayman, James A., Mancini, Brandon, Jagsi, Reshma, Pierce, Lori, Moran, Jean M., Dominello, Michael M., Boike, Thomas, Griffith, Kent, Jolly, Shruti, and Spratt, Daniel E.
- Abstract
Single-fraction (SF) radiation therapy is effective and convenient for patients with painful noncomplex bone metastases. Prior survey results reported a low recommendation of SF radiation therapy in the US. We sought to assess contemporary treatment recommendations for the management of bone metastases among diverse physicians participating in a statewide quality consortium. Members of the Michigan Radiation Oncology Quality Consortium were surveyed between April and May 2017. Physicians rated the importance of 31 variables on their choice of dose fractionation. The survey also covered 7 patient scenarios. Fifty-six physicians responded who were practicing at 18 of 20 centers surveyed. Respondents recommended 23 dose-fractionation schedules across the 7 scenarios. Highest-rated factors considered when choosing a dose fractionation regimen were performance status, prognosis, spinal cord compression, and prior radiation therapy. Recommendations for SF overall were uncommon (16.1%). On multivariable analysis, factors associated with SF use included academic employment (odds ratio [OR] 2.04; 95% CI, 1.02-4.08; P =.044) and higher palliative case volume (OR 2.59; 95% CI, 1.45-4.63; P =.001). Stereotactic body radiation therapy (SBRT) was recommended in 16.4% of scenarios overall, and on multivariable analysis, significant predictors for SBRT use were academic employment (OR 2.99; 95% CI, 1.39-6.44; P =.005), more recent residency completion (OR 4.37; 95% CI, 1.26-15.17; P =.02), spine location (OR 12.54; 95% CI, 3.96-39.68; P <.001), and prior radiation therapy (OR 26.67; 95% CI, 7.86-90.57; P <.001). SF rates were higher than in a survey reported in 2009 (16.1% vs 9.4%, P =.0004). SF radiation therapy remains uncommonly recommended, although it may be recommended more now than it was 10 years ago despite the increased utilization of SBRT. We identify multiple key drivers in physician decision making affecting SF recommendations that have not been addressed by prior level one evidence. Further research with evidence-based recommendations to clarify the role of SF and SBRT in management of patients with bony metastases are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
26. Readability of Patient Education Materials in Radiation Oncology—Are We Improving?
- Author
-
Rooney, Michael K., Sachdev, Sean, Byun, John, Jagsi, Reshma, and Golden, Daniel W.
- Abstract
Prior research suggests that patient education materials on radiation therapy from various professional groups are written at reading levels above national recommendations of sixth to eighth grade. Since publication of these initial findings, many materials from these sources have been updated or newly created. However, the extent to which readability was considered in the design of these new documents remains unknown. Therefore, the goal of this investigation was to evaluate readability of online education materials for radiation therapy, comparing readability of updated materials with those included in the previous study. Patient education materials related to radiation oncology were identified from websites of the 3 professional societies used in the original investigation (the American College of Radiology, the American Cancer Society, and the American Society for Radiation Oncology). The documents included in the first analysis were used as a comparator. To allow for accurate evaluation across groups, materials were matched by content; when necessary, documents were combined from the original cohort to create topically equivalent materials to reflect those currently available on society websites. Identified materials were analyzed using 7 validated readability indices, and results are reported in grade-level equivalents. Original materials were also reanalyzed with the same method. American Cancer Society materials had the lowest average baseline levels (9.4-11.3 grade level) and showed improved readability in the more recent materials (8.0-10.5 grade level). By contrast, the American Society for Radiation Oncology materials had high average baseline readability levels (11.1-13.9 grade level) that actually worsened in the more recent materials (11.7-16.2 grade level). The number of documents meeting national recommendations did not improve in the updated cohort. Despite evidence that readability levels of patient education materials in radiation oncology are unacceptably high, the readability of newly created materials is not consistently improving across professional societies. Although certain groups may incorporate readability in the design of educational documents, more consistent consideration across all organizations is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
27. Women in radiation oncology: time to break through the glass ceiling
- Author
-
Jagsi, Reshma and Tarbell, Nancy J.
- Subjects
Women in medicine -- Evaluation ,Radiologists -- Demographic aspects ,Sex discrimination against women -- Evaluation ,Medical societies -- Membership ,Health - Published
- 2006
28. Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients.
- Author
-
Gay, Hiram A., Santiago, Roberto, Gil, Betty, Remedios, Carlos, Montes, Pedro J., López-Araujo, Javier, Chévere, Carlos M., Imbert, Winston S., White, Julia, Arthur, Douglas W., Horton, Janet K., Jagsi, Reshma, Rabinovich, Rachel, Beriwal, Sushil, Viswanathan, Akila, Erickson, Beth A., Rengan, Ramesh, Palma, David, Loo, Billy W., and Kavanaugh, James A.
- Published
- 2019
- Full Text
- View/download PDF
29. Quality at the American Society for Radiation Oncology Annual Meeting: Gender Balance Among Invited Speakers and Associations with Panel Success.
- Author
-
Rahimy, Elham, Jagsi, Reshma, Park, Henry S., Moran, Jean M., Cervino, Laura, Albert, Ashley, Lee, Anna, and Evans, Suzanne
- Subjects
- *
ANNUAL meetings , *GENDER , *RADIOTHERAPY , *H-index (Citation analysis) , *ONCOLOGY , *RADIATION - Abstract
Purpose: The American Society for Radiation Oncology (ASTRO) annual meeting is the most prominent international conference in radiation oncology. It represents one of the greatest time efforts for ASTRO volunteers, and the quality of the annual meeting is a high priority. Measures of diversity have been linked with quality of academic efforts. We conducted a study of gender diversity of the ASTRO invited speakers, focusing on speaker and panel characteristics, and associations of these characteristics with measures of audience satisfaction.Methods and Materials: We created a database of all invited speakers (n = 1499 cumulative speaking positions, n = 725 individual speakers) and panels (n = 381) in the ASTRO annual meetings from 2012 to 2016. Speaker characteristics were acquired using publically available online search tools (including Scopus for citation metrics). SAS software was used for statistical analysis.Results: Of the 725 individual speakers, 27% were women. Men had higher median Hirsch index (H-index) (27 vs 20, P < .001), M-index (1.36 vs 1.11, P < .001), earlier first publication (1994 vs 1997), professorship (57% vs 40%, P < .001), chair status (25% vs 14%, P < .001) and fellow designations/distinctions (ie, FASTRO/FACR/FAAPM) (12% vs 9.5%, P < .17). Median panel gender distribution was 25% female, and greatest female representation was in breast, gynecology, and pediatrics. On multivariable analysis, panel characteristics associated with individual measures of audience satisfaction included single discipline presentations (metric: overall evaluation score), panels not proposed or endorsed by committee (metric: room count), higher H-index (metric: room count) and M-index (metric: request for session repeat), and panels with gender composition >50% female (metric: request for session repeat). Female conveners were associated with greater panel gender diversity.Conclusion: Given observations that women constitute a minority of invited speakers and that greater female representation correlates with a key panel success metric, efforts to ensure greater diversity of those included in AM speaking invitations merit serious attention. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
30. Gender Diversity in Radiation Oncology Board Certification.
- Author
-
Knoll, Miriam A., Jagsi, Reshma, and Wallner, Paul
- Subjects
- *
RADIATION , *ONCOLOGY , *GENDER , *COMPARATIVE studies , *RESEARCH methodology , *MEDICAL cooperation , *RADIOTHERAPY , *RESEARCH , *SEX distribution , *CERTIFICATION , *EVALUATION research - Published
- 2020
- Full Text
- View/download PDF
31. Importance of First and Second Authorship in Assessing Citation-Based Scholarly Activity of US Radiation Oncology Residents and Subsequent Choice of Academic Versus Private Practice Career.
- Author
-
IIIMcClelland, Shearwood, Mitin, Timur, Jagsi, Reshma, Jr.Thomas, Charles R., Jaboin, Jerry J., McClelland, Shearwood 3rd, and Thomas, Charles R Jr
- Abstract
Purpose: The Hirsch index (h-index) has been shown to correlate with radiation oncology residents' having a first job in academics versus private practice, but it is limited by its inability to distinguish between the differing significance of coauthor roles in articles.Methods: A list of 2016 radiation oncology resident graduates and their postresidency career choices was compiled. The Scopus bibliometric citation database was then searched to collect h-index data for articles limited to first author only (hf) and first or second-author only (hs) for each resident.Results: Mean hf was 2.06 for all resident graduates, and mean hs was 2.77. Residents with PhDs had significantly higher hf (3.11 versus 1.76, P < .01) and hs (4.50 versus 2.28, P < .01). There was no statistically significant difference between male and female residents for hf (2.19 versus 1.61, P = .11) or hs (2.91 versus 2.25, P = .15). Residents choosing academia had higher hf (2.72 versus 1.44, P < .01) and hs (3.57 versus 2.01, P < 0.01) than those in private practice. Fewer than 20% of graduates with hf = 0 and only 10% of graduates with hs = 0 secured academic jobs.Conclusion: The average radiation oncology resident graduate has published a minimum of two first- and/or second-author articles cited at least twice. Graduates with PhDs and/or choosing academic careers were more likely to have higher hf and hs scores; there was no significant score difference by gender. Only 10% of graduates without any first- and/or second-author articles cited at least once secured academic jobs. These findings indicate that stratifying publications by first or second authorship when developing benchmarks for evaluating resident productivity and postresidency career type may be useful. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
32. A Randomized Comparison of Radiation Therapy Techniques in the Management of Node-Positive Breast Cancer: Primary Outcomes Analysis.
- Author
-
Jagsi, Reshma, Moran, Jean M., Marsh, Robin, Dess, Robert T., Chung, Eugene, Liss, Adam L., Hayman, James A., Mayo, Charles S., Pierce, Lori, Griffith, Kent A., Ficaro, Edward, Corbett, James, and Flaherty, Kevin
- Subjects
- *
RADIOTHERAPY , *BREAST cancer treatment , *BREATH holding , *SINGLE-photon emission computed tomography , *RANDOMIZED controlled trials , *ALGORITHMS , *BREAST tumors , *COMPARATIVE studies , *LUNGS , *LYMPH nodes , *RESEARCH methodology , *MEDICAL cooperation , *COMPUTERS in medicine , *METASTASIS , *PERFUSION , *RADIATION doses , *RADIATION measurements , *RADIATION injuries , *RESEARCH , *RESEARCH funding , *PULMONARY function tests , *EVALUATION research , *TREATMENT effectiveness - Abstract
Purpose: Although inverse-planned intensity modulated radiotherapy (IMRT) and deep inspiration breath hold (DIBH) may allow for more conformal dose distributions, it is unknown whether using these technologies reduces cardiac or pulmonary toxicity of breast radiotherapy.Methods and Materials: A randomized controlled trial compared IMRT-DIBH versus standard, free-breathing, forward-planned, three-dimensional conformal radiotherapy in patients with left-sided, node-positive breast cancer in whom the internal mammary nodal region was targeted. Endpoints included dosimetric parameters and changes in pulmonary and cardiac perfusion and function, measured by single photon emission computed tomography (SPECT) scans and pulmonary function testing performed at baseline and 1 year post treatment.Results: Of 62 patients randomized, 54 who completed all follow-up procedures were analyzed. Mean doses to the ipsilateral lung, left ventricle, whole heart, and left anterior descending coronary artery were lower with IMRT-DIBH; the percent of left ventricle receiving ≥5 Gy averaged 15.8% with standard radiotherapy and 5.6% with IMRT-DIBH (P < .001). SPECT revealed no differences in perfusion defects in the left anterior descending coronary artery territory, the study's primary endpoint, but did reveal statistically significant differences (P = .02) in left ventricular ejection fraction (LVEF), a secondary endpoint. No differences were found for lung perfusion or function.Conclusion: The small but statistically significant benefit in preservation of cardiac LVEF observed here should motivate future studies that include LVEF as a potentially meaningful endpoint. Future studies should disaggregate the impact of IMRT from that of DIBH. Clinical practice should recognize the importance of minimizing cardiac dose, even when already low in comparison to historical levels. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
33. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
- Author
-
Smith, Benjamin D., Bellon, Jennifer R., Blitzblau, Rachel, Freedman, Gary, Haffty, Bruce, Hahn, Carol, Halberg, Francine, Hoffman, Karen, Horst, Kathleen, Moran, Jean, Patton, Caroline, Perlmutter, Jane, Warren, Laura, Whelan, Timothy, Wright, Jean L., and Jagsi, Reshma
- Abstract
Introduction The purpose of this guideline is to offer recommendations on fractionation for whole breast irradiation (WBI) with or without a tumor bed boost and guidance on treatment planning and delivery. Methods and materials The American Society for Radiation Oncology (ASTRO) convened a task force to address 5 key questions focused on dose-fractionation for WBI, indications and dose-fractionation for tumor bed boost, and treatment planning techniques for WBI and tumor bed boost. Guideline recommendations were based on a systematic literature review and created using a predefined consensus-building methodology supported by ASTRO-approved tools for grading evidence quality and recommendation strength. Results For women with invasive breast cancer receiving WBI with or without inclusion of the low axilla, the preferred dose-fractionation scheme is hypofractionated WBI to a dose of 4000 cGy in 15 fractions or 4250 cGy in 16 fractions. The guideline discusses factors that might or should affect fractionation decisions. Use of boost should be based on shared decision-making that considers patient, tumor, and treatment factors, and the task force delineates specific subgroups in which it recommends or suggests use or omission of boost, along with dose recommendations. When planning, the volume of breast tissue receiving >105% of the prescription dose should be minimized and the tumor bed contoured with a goal of coverage with at least 95% of the prescription dose. Dose to the heart, contralateral breast, lung, and other normal tissues should be minimized. Conclusions WBI represents a significant portion of radiation oncology practice, and these recommendations are intended to offer the groundwork for defining evidence-based practice for this common and important modality. This guideline also seeks to promote appropriately individualized, shared decision-making regarding WBI between physicians and patients. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
34. Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy.
- Author
-
Horton, Janet K, Jagsi, Reshma, Woodward, Wendy A, and Ho, Alice
- Abstract
Historically, prognosis and treatment decision making for breast cancer patients have been dictated by the anatomic extent of tumor spread. However, in recent years, "breast cancer" has proven to be a collection of unique phenotypes with distinct prognoses, patterns of failure, and treatment responses. Recent advances in biologically based assays and targeted therapies designed to exploit these unique phenotypes have profoundly altered systemic therapy practice patterns and treatment outcomes. Data associating locoregional outcomes with tumor biology are emerging. However, the likelihood of obtaining level I evidence for fundamental radiation therapy questions within each of the specific subtypes in the immediate future is low. As such, this review aims to summarize the existing data and provide practical context for the incorporation of breast tumor biology into clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
35. Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer.
- Author
-
Kapadia, Nirav S., Valle, Luca F., George, Julie A., Jagsi, Reshma, D’Amico, Thomas A., Dexter, Elisabeth U., Vigneau, Fawn D., and Kong, Feng Ming
- Abstract
Background Definitive surgical and radiation therapy (RT) treatments are evolving rapidly for stage I non-small cell lung cancer (NSCLC). We hypothesized that utilization of definitive therapies increased between 2000 and 2010 and that survival improved for stage I NSCLC patients over the same time period. Secondary objectives were determining trends in patterns of care and predictors of utilization. Methods Population-based, observational, comparative effectiveness study used Surveillance, Epidemiology, and End Results-18 data from 2000 to 2010. The main outcome measure was 2-year risk of death for stage I NSCLC. Results Between 2000 and 2010, 40,589 patients (62%) underwent surgery, 10,048 (15%) received RT, 2,130 (3%) received both surgery and RT, and 11,537 (18%) received neither surgery nor RT. Annually, the odds of receiving either definitive RT or undergoing surgery increased relative to the odds of receiving no treatment (odds ratio [OR] radiation 1.04, 95% confidence interval [CI]: 1.03 to 1.05; OR surgery 1.05, 95% CI: 1.04 to 1.05). Among surgical patients, the proportion of sublobar resections steadily increased from 12.9% to 17.9%. For all patients, the 2-year risk of death decreased by 3.5% each year (hazard ratio [HR] 0.965, 95% CI: 0.962 to 0.969), driven primarily by improved survival for surgical (annualized HR 0.959, 95% CI: 0.954 to 0.964) and RT (annualized HR 0.942, 95% CI: 0.935 to 0.949) patients. Conclusions Between 2000 and 2010, stage I NSCLC patients were more likely to receive definitive treatment with either surgery or RT, leading to a decline in the number of untreated patients. Survival also improved substantially for stage I NSCLC patients, with the largest survival improvements observed in patients undergoing definitive RT. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
36. The Ethical Imperative and Evidence-Based Strategies to Ensure Equity and Diversity in Radiation Oncology.
- Author
-
Chapman, Christina Hunter and Jagsi, Reshma
- Subjects
- *
RADIOTHERAPY , *WOMEN medical students , *ONCOLOGY , *MEDICAL students , *PHYSICIAN-patient relations , *EDUCATION , *RACISM , *EMPLOYEE selection , *CULTURAL pluralism , *EMPLOYEE reviews , *SEXISM , *ACHIEVEMENT , *STANDARDS , *ETHICS - Published
- 2017
- Full Text
- View/download PDF
37. Breast and Prostate Cancer: Lessons to Be Shared.
- Author
-
Spratt, Daniel E. and Jagsi, Reshma
- Subjects
- *
BREAST cancer treatment , *PROSTATE cancer treatment , *ANDROGEN drugs , *CANCER radiotherapy , *MASTECTOMY , *BREAST tumor diagnosis , *BREAST tumor treatment , *PROSTATE tumors , *PROSTATE tumors treatment , *COMBINED modality therapy , *ENDOWMENT of research , *LIFE expectancy , *TERMS & phrases , *DIAGNOSIS - Published
- 2017
- Full Text
- View/download PDF
38. Hypofractionated radiotherapy after mastectomy: a new frontier.
- Author
-
Jagsi, Reshma
- Subjects
- *
MASTECTOMY , *RADIOTHERAPY , *RADIATION doses , *BREAST cancer treatment - Published
- 2019
- Full Text
- View/download PDF
39. Gender Differences in Endowed Chairs in Pediatrics.
- Author
-
Singer, Kanakadurga, Burns, Courtney Julia, Griffith, Kent A., Opipari, Valerie Castle, Martin, Donna M., Shellhaas, Renée A., and Jagsi, Reshma
- Published
- 2022
- Full Text
- View/download PDF
40. Work Activities and Compensation of Male and Female Cardiologists.
- Author
-
Jagsi, Reshma, Biga, Cathie, Poppas, Athena, Rodgers, George P., Walsh, Mary N., White, Patrick J., McKendry, Colleen, Sasson, Joseph, Schulte, Phillip J., and Douglas, Pamela S.
- Subjects
- *
CARDIOLOGISTS , *WOMEN in medicine , *NONINVASIVE diagnostic tests , *WAGES , *POSITRON emission tomography , *WAGE statistics , *CARDIOLOGY , *JOB satisfaction , *PERSONNEL management , *SEX distribution , *WOMEN physicians , *WORK , *ECONOMICS - Abstract
Background: Much remains unknown about experiences, including working activities and pay, of women in cardiology, which is a predominantly male specialty.Objectives: The goal of this study was to describe the working activities and pay of female cardiologists compared with their male colleagues and to determine whether sex differences in compensation exist after accounting for differences in work activities and other characteristics.Methods: The personal, job, and practice characteristics of a national sample of practicing cardiologists were described according to sex. We applied the Peters-Belson technique and multivariate regression analysis to evaluate whether gender differences in compensation existed after accounting for differences in other measured characteristics. The study used 2013 data reported by practice administrators to MedAxiom, a subscription-based service provider to cardiology practices. Data regarding cardiologists from 161 U.S. practices were included, and the study sample included 2,679 subjects (229 women and 2,450 men).Results: Women were more likely to be specialized in general/noninvasive cardiology (53.1% vs. 28.2%), and a lower proportion (11.4% vs. 39.3%) reported an interventional subspecialty compared with men. Job characteristics that differed according to sex included the proportion working full-time (79.9% vs. 90.9%; p < 0.001), the mean number of half-days worked (387 vs. 406 days; p = 0.001), and mean work relative value units generated (7,404 vs. 9,497; p < 0.001) for women and men, respectively. Peters-Belson analysis revealed that based on measured job and productivity characteristics, the women in this sample would have been expected to have a mean salary that was $31,749 (95% confidence interval: $16,303 to $48,028) higher than that actually observed. Multivariate analysis confirmed the direction and magnitude of the independent association between sex and salary.Conclusions: Men and women practicing cardiology in this national sample had different job activities and salaries. Substantial sex-based salary differences existed even after adjusting for measures of personal, job, and practice characteristics. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
41. Variation in Definitive Therapy for Localized Non-Small Cell Lung Cancer Among National Comprehensive Cancer Network Institutions.
- Author
-
Valle, Luca F., Jagsi, Reshma, Bobiak, Sarah N., Zornosa, Carrie, D'Amico, Thomas A., Pisters, Katherine M., Dexter, Elisabeth U., Niland, Joyce C., Hayman, James A., Kapadia, Nirav S., and D'Amico, Thomas A
- Subjects
- *
NON-small-cell lung carcinoma , *MEDICAL practice , *CANCER radiotherapy , *MEDICAL decision making , *MEDICAL databases , *HEALTH outcome assessment , *BRAIN tumors , *COMPARATIVE studies , *DECISION making , *ENDOSCOPY , *LUNG cancer , *LUNG tumors , *RESEARCH methodology , *MEDICAL cooperation , *RADIOTHERAPY , *RESEARCH , *SURGICAL complications , *TUMOR classification , *EVALUATION research , *STANDARDS ,BRAIN tumor diagnosis - Abstract
Purpose: This study determined practice patterns in the staging and treatment of patients with stage I non-small cell lung cancer (NSCLC) among National Comprehensive Cancer Network (NCCN) member institutions. Secondary aims were to determine trends in the use of definitive therapy, predictors of treatment type, and acute adverse events associated with primary modalities of treatment.Methods and Materials: Data from the National Comprehensive Cancer Network Oncology Outcomes Database from 2007 to 2011 for US patients with stage I NSCLC were used. Main outcome measures included patterns of care, predictors of treatment, acute morbidity, and acute mortality.Results: Seventy-nine percent of patients received surgery, 16% received definitive radiation therapy (RT), and 3% were not treated. Seventy-four percent of the RT patients received stereotactic body RT (SBRT), and the remainder received nonstereotactic RT (NSRT). Among participating NCCN member institutions, the number of surgeries-to-RT course ratios varied between 1.6 and 34.7 (P<.01), and the SBRT-to-NSRT ratio varied between 0 and 13 (P=.01). Significant variations were also observed in staging practices, with brain imaging 0.33 (0.25-0.43) times as likely and mediastinoscopy 31.26 (21.84-44.76) times more likely for surgical patients than for RT patients. Toxicity rates for surgical and for SBRT patients were similar, although the rates were double for NSRT patients.Conclusions: The variations in treatment observed among NCCN institutions reflects the lack of level I evidence directing the use of surgery or SBRT for stage I NSCLC. In this setting, research of patient and physician preferences may help to guide future decision making. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
42. Considerations for Observational Research Using Large Data Sets in Radiation Oncology.
- Author
-
Jagsi, Reshma, Bekelman, Justin E., Chen, Aileen, Chen, Ronald C., Hoffman, Karen, Shih, Ya-Chen Tina, Smith, Benjamin D., and Yu, James B.
- Subjects
- *
ONCOLOGY research , *SCIENTIFIC observation , *BIG data , *CANCER radiotherapy , *CANCER patient medical care , *CLINICAL trials - Abstract
The radiation oncology community has witnessed growing interest in observational research conducted using large-scale data sources such as registries and claims-based data sets. With the growing emphasis on observational analyses in health care, the radiation oncology community must possess a sophisticated understanding of the methodological considerations of such studies in order to evaluate evidence appropriately to guide practice and policy. Because observational research has unique features that distinguish it from clinical trials and other forms of traditional radiation oncology research, the International Journal of Radiation Oncology, Biology, Physics assembled a panel of experts in health services research to provide a concise and well-referenced review, intended to be informative for the lay reader, as well as for scholars who wish to embark on such research without prior experience. This review begins by discussing the types of research questions relevant to radiation oncology that large-scale databases may help illuminate. It then describes major potential data sources for such endeavors, including information regarding access and insights regarding the strengths and limitations of each. Finally, it provides guidance regarding the analytical challenges that observational studies must confront, along with discussion of the techniques that have been developed to help minimize the impact of certain common analytical issues in observational analysis. Features characterizing a well-designed observational study include clearly defined research questions, careful selection of an appropriate data source, consultation with investigators with relevant methodological expertise, inclusion of sensitivity analyses, caution not to overinterpret small but significant differences, and recognition of limitations when trying to evaluate causality. This review concludes that carefully designed and executed studies using observational data that possess these qualities hold substantial promise for advancing our understanding of many unanswered questions of importance to the field of radiation oncology. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
43. Attitudes Toward Blinding of Peer Review and Perceptions of Efficacy Within a Small Biomedical Specialty.
- Author
-
Jagsi, Reshma, Bennett, Katherine Egan, Griffith, Kent A., DeCastro, Rochelle, Grace, Calley, Holliday, Emma, and Zietman, Anthony L.
- Subjects
- *
MEDICAL sciences , *DEMOGRAPHIC surveys , *SENSORY perception , *BLIND experiment , *HEALTH outcome assessment - Abstract
Purpose Peer reviewers' knowledge of author identity may influence review content, quality, and recommendations. Therefore, the International Journal of Radiation Oncology, Biology, Physics ("Red Journal") implemented double-blinded peer review in 2011. Given the relatively small size of the specialty and the high frequency of preliminary abstract presentations, we sought to evaluate attitudes, the efficacy of blinding, and the potential impact on the disposition of submissions. Methods and Materials In May through August 2012, all Red Journal reviewers and 1 author per manuscript completed questionnaires regarding demographics, attitudes, and perceptions of success of blinding. We also evaluated correlates of the outcomes of peer review. Results Questionnaires were received from 408 authors and 519 reviewers (100%). The majority of respondents favored double blinding; 6% of authors and 13% of reviewers disagreed that double blinding should continue in the Red Journal. In all, 50% of the reviewers did not suspect the identity of the author of the paper that they reviewed; 19% of reviewers believed that they could identify the author(s), and 31% suspected that they could. Similarly, 23% believed that they knew the institution(s) from which the paper originated, and 34% suspected that they did. Among those who at least suspected author identity, 42% indicated that prior presentations served as a clue, and 57% indicated that literature referenced did so. Of those who at least suspected origin and provided details (n=133), 13% were entirely incorrect. Rejection was more common in 2012 than 2011, and submissions from last authors with higher H-indices (>21) were more likely to survive initial review, without evidence of interactions between submission year and author gender or H-index. Conclusions In a relatively small specialty in which preliminary research presentations are common and occur in a limited number of venues, reviewers are often familiar with research findings and suspect author identity even when manuscript review is blinded. Nevertheless, blinding appears to be effective in many cases, and support for continuing blinding was strong. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
44. Sex, Role Models, and Specialty Choices Among Graduates of US Medical Schools in 2006–2008.
- Author
-
Jagsi, Reshma, Griffith, Kent A., DeCastro, Rochelle A., and Ubel, Peter
- Subjects
- *
MEDICAL school graduates , *MEDICAL schools , *SEX (Biology) , *HYPOTHESIS , *LOGISTIC regression analysis , *LEADERSHIP , *DECISION making - Abstract
Background: Undergraduate education studies have suggested instructor sex can influence female students to pursue a discipline. We sought to evaluate a similar hypothesis in medical students. Study Design: We obtained Association of American Medical Colleges (AAMC) data about the specialization of 2006–2008 graduates of US medical schools, the sex of their faculty and department chairs, and sex of residents in the residency programs in which they enrolled. We used logistic regression to examine associations between faculty and leadership sex and female students' pursuit of 5 surgical specialties along with 3 nonsurgical specialties for context. We used Wilcoxon rank-sum tests to evaluate whether women entered residency programs with a higher proportion of female residents. Results: In 2006–2008, US medical school graduates included 23,642 women. Women were substantially under-represented among residents in neurosurgery, orthopaedics, urology, otolaryngology, general surgery, and radiology; women constituted 47.4% of US graduates specializing in internal medicine and 74.9% in pediatrics. We found no significant associations between exposure to a female department chair and selection of that specialty and no consistent associations with the proportion of female full-time faculty. Compared with male students, female students entered residency programs in their chosen specialty that had significantly higher proportions of women residents in the year before their graduation. Conclusions: Although we did not detect consistent significant associations between exposure to potential female faculty role models and specialty choice, we observed that female students were more likely than males to enter programs with higher proportions of female residents. Sex differences in students' specialization decisions merit additional investigation. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
45. Standing on the Shoulders of Giants: Results From the Radiation Oncology Academic Development and Mentorship Assessment Project (ROADMAP).
- Author
-
Holliday, Emma B., Jagsi, Reshma, Thomas, Charles R., Wilson, Lynn D., and Fuller, Clifton D.
- Subjects
- *
CANCER radiotherapy , *DOCTOR of philosophy degree , *H-index (Citation analysis) , *CAREER development , *MENTORING , *ONCOLOGY - Abstract
Purpose: To analyze survey information regarding mentorship practices and cross-correlate the results with objective metrics of academic productivity among academic radiation oncologists at US Accreditation Council for Graduate Medical Education (ACGME)-accredited residency training programs. Methods and Materials: An institutional review board-approved survey for the Radiation Oncology Academic Development and Mentorship Assessment Project (ROADMAP) was sent to 1031 radiation oncologists employed at an ACGME-accredited residency training program and administered using an international secure web application designed exclusively to support data capture for research studies. Data collected included demographics, presence of mentorship, and the nature of specific mentoring activities. Productivity metrics, including number of publications, number of citations, h-index, and date of first publication, were collected for each survey respondent from a commercially available online database, and m-index was calculated. Results: A total of 158 academic radiation oncologists completed the survey, 96 of whom reported having an academic/scientific mentor. Faculty with a mentor had higher numbers of publications, citations, and h- and m-indices. Differences in gender and race/ethnicity were not associated with significant differences in mentorship rates, but those with a mentor were more likely to have a PhD degree and were more likely to have more time protected for research. Bivariate fit regression modeling showed a positive correlation between a mentor's h-index and their mentee's h-index (R2 = 0.16; P<.001). Linear regression also showed significant correlates of higher h-index, in addition to having a mentor (P=.001), included a longer career duration (P<.001) and fewer patients in treatment (P=.02). Conclusions: Mentorship is widely believed to be important to career development and academic productivity. These results emphasize the importance of identifying and striving to overcome potential barriers to effective mentorship. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
46. In Reply to Ling and Beriwal.
- Author
-
Jagsi, Reshma, Griffith, Kent, Moran, Jean M., Vicini, Frank, and Pierce, Lori
- Published
- 2022
- Full Text
- View/download PDF
47. A Research Agenda for Radiation Oncology: Results of the Radiation Oncology Institute’s Comprehensive Research Needs Assessment
- Author
-
Jagsi, Reshma, Bekelman, Justin E., Brawley, Otis W., Deasy, Joseph O., Le, Quynh-Thu, Michalski, Jeff M., Movsas, Benjamin, Thomas, Charles R., Lawton, Colleen A., Lawrence, Theodore S., and Hahn, Stephen M.
- Subjects
- *
CANCER radiotherapy , *CANCER research , *TREATMENT effectiveness , *HEALTH surveys - Abstract
Purpose: To promote the rational use of scarce research funding, scholars have developed methods for the systematic identification and prioritization of health research needs. The Radiation Oncology Institute commissioned an independent, comprehensive assessment of research needs for the advancement of radiation oncology care. Methods and Materials: The research needs assessment used a mixed-method, qualitative and quantitative social scientific approach, including structured interviews with diverse stakeholders, focus groups, surveys of American Society for Radiation Oncology (ASTRO) members, and a prioritization exercise using a modified Delphi technique. Results: Six co-equal priorities were identified: (1) Identify and develop communication strategies to help patients and others better understand radiation therapy; (2) Establish a set of quality indicators for major radiation oncology procedures and evaluate their use in radiation oncology delivery; (3) Identify best practices for the management of radiation toxicity and issues in cancer survivorship; (4) Conduct comparative effectiveness studies related to radiation therapy that consider clinical benefit, toxicity (including quality of life), and other outcomes; (5) Assess the value of radiation therapy; and (6) Develop a radiation oncology registry. Conclusions: To our knowledge, this prioritization exercise is the only comprehensive and methodologically rigorous assessment of research needs in the field of radiation oncology. Broad dissemination of these findings is critical to maximally leverage the impact of this work, particularly because grant funding decisions are often made by committees on which highly specialized disciplines such as radiation oncology are not well represented. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
48. Coordination of Breast Cancer Care Between Radiation Oncologists and Surgeons: A Survey Study
- Author
-
Jagsi, Reshma, Abrahamse, Paul, Morrow, Monica, Hamilton, Ann S., Graff, John J., and Katz, Steven J.
- Subjects
- *
BREAST cancer treatment , *CANCER radiotherapy , *ONCOLOGISTS , *SURGEONS , *DECISION making in clinical medicine , *HEALTH surveys , *MEDICAL statistics - Abstract
Purpose: To assess whether radiation oncologists and surgeons differ in their attitudes regarding the local management of breast cancer, and to examine coordination of care between these specialists. Methods and Materials: We surveyed attending surgeons and radiation oncologists who treated a population-based sample of patients diagnosed with breast cancer in metropolitan Detroit and Los Angeles. We identified 419 surgeons, of whom 318 (76%) responded, and 160 radiation oncologists, of whom 117 (73%) responded. We assessed demographic, professional, and practice characteristics; challenges to coordinated care; and attitudes toward management in three scenarios. Results: 92.1% of surgeons and 94.8% of radiation oncologists indicated access to a multidisciplinary tumor board. Nevertheless, the most commonly identified challenge to radiation oncologists, cited by 27.9%, was failure of other providers to include them in the treatment decision process early enough. Nearly half the surgeons (49.7%) stated that few or almost none of the breast cancer patients they saw in the past 12 months had consulted with a radiation oncologist before undergoing definitive surgery. Surgeons and radiation oncologists differed in their recommendations in management scenarios. Radiation oncologists were more likely to favor radiation than were surgeons for a patient with 3/20 lymph nodes undergoing mastectomy (p = 0.03); surgeons were more likely to favor more widely clear margins after breast conservation than were radiation oncologists (p = 0.001). Conclusions: Despite the widespread availability of tumor boards, a substantial minority of radiation oncologists indicated other providers failed to include them in the breast cancer treatment decision-making process early enough. Earlier inclusion of radiation oncologists may influence patient decisions, and interventions to facilitate this should be considered. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
49. Evaluation of Four Techniques Using Intensity-Modulated Radiation Therapy for Comprehensive Locoregional Irradiation of Breast Cancer
- Author
-
Jagsi, Reshma, Moran, Jean, Marsh, Robin, Masi, Kathryn, Griffith, Kent A., and Pierce, Lori J.
- Subjects
- *
CANCER radiotherapy , *BREAST cancer diagnosis , *DIAGNOSTIC imaging , *LUMPECTOMY , *CORONARY disease , *MAMMARY glands , *DRUG dosage , *CANCER treatment - Abstract
Purpose: To establish optimal intensity-modulated radiation therapy (IMRT) techniques for treating the left breast and regional nodes, using moderate deep-inspiration breath hold. Methods and Materials: We developed four IMRT plans of differing complexity for each of 10 patients following lumpectomy for left breast cancer. A dose of 60 Gy was prescribed to the boost planning target volume (PTV) and 52.2 Gy to the breast and supraclavicular, infraclavicular, and internal mammary nodes. Two plans used inverse-planned beamlet techniques: a 9-field technique, with nine equispaced axial beams, and a tangential beamlet technique, with three to five ipsilateral beams. The third plan (a segmental technique) used a forward-planned multisegment technique, and the fourth plan (a segmental blocked technique) was identical but included a block to limit heart dose. Dose--volume histograms were generated, and metrics chosen for comparison were analyzed using the paired t test. Results: Mean heart and left anterior descending coronary artery doses were similar with the tangential beamlet and segmental blocked techniques but higher with the segmental and 9-field techniques (mean paired difference of 15.1 Gy between segmental and tangential beamlet techniques, p < 0.001). Substantial volumes of contralateral tissue received dose with the 9-field technique (mean right breast V2, 58.9%; mean right lung V2, 75.3%). Minimum dose to ≥95% of breast PTV was, on average, 45.9 Gy with tangential beamlet, 45.0 Gy with segmental blocked, 51.4 Gy with segmental, and 50.2 Gy with 9-field techniques. Coverage of the internal mammary region was substantially better with the two beamlet techniques than with the segmental blocked technique. Conclusions: Compared to the 9-field beamlet and segmental techniques, a tangential beamlet IMRT technique reduced exposure to normal tissues and maintained reasonable target coverage. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
50. Unacceptable Cosmesis in a Protocol Investigating Intensity-Modulated Radiotherapy With Active Breathing Control for Accelerated Partial-Breast Irradiation
- Author
-
Jagsi, Reshma, Ben-David, Merav A., Moran, Jean M., Marsh, Robin B., Griffith, Kent A., Hayman, James A., and Pierce, Lori J.
- Subjects
- *
CANCER radiotherapy , *MEDICAL protocols , *LONGITUDINAL method , *BREAST cancer patients , *TOXICITY testing , *FOLLOW-up studies (Medicine) , *RETROSPECTIVE studies , *CLINICAL trials - Abstract
Purpose: To report interim cosmetic results and toxicity from a prospective study evaluating accelerated partial-breast irradiation (APBI) administered using a highly conformal external beam approach. Methods and Materials: We enrolled breast cancer patients in an institutional review board–approved prospective study of APBI using beamlet intensity-modulated radiotherapy (IMRT) at deep-inspiration breath-hold. Patients received 38.5 Gy in 3.85 Gy fractions twice daily. Dosimetric parameters in patients who maintained acceptable cosmesis were compared with those in patients developing unacceptable cosmesis in follow-up, using t-tests. Results: Thirty-four patients were enrolled; 2 were excluded from analysis because of fair baseline cosmesis. With a median follow-up of 2.5 years, new unacceptable cosmesis developed in 7 patients, leading to early study closure. We compared patients with new unacceptable cosmesis with those with consistently acceptable cosmesis. Retrospective analysis demonstrated that all but one plan adhered to the dosimetric requirements of the national APBI trial. The mean proportion of a whole-breast reference volume receiving 19.25 Gy (V50) was lower in patients with acceptable cosmesis than in those with unacceptable cosmesis (34.6% vs. 46.1%; p = 0.02). The mean percentage of this reference volume receiving 38.5 Gy (V100) was also lower in patients with acceptable cosmesis (15.5% vs. 23.0%; p = 0.02). Conclusions: The hypofractionated schedule and parameters commonly used for external beam APBI and prescribed by the ongoing national trial may be suboptimal, at least when highly conformal techniques such as IMRT with management of breathing motion are used. The V50 and V100 of the breast reference volume seem correlated with cosmetic outcome, and stricter limits may be appropriate in this setting. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.